This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
An AI model that detects low bone mineral density (BMD) on ankle and foot x-rays could be useful for screening for osteoporosis, according to radiologists at MD Anderson Cancer Center in Houston. Given that gold standard dual-energy x-ray absorptiometry (DEXA) scans are underused in screening, the tool could be used opportunistically, the researchers noted.
Onc.AI, a developer of AI-driven oncology clinical management software, has received breakthrough device designation from the U.S. Food and Drug Administration (FDA) for the company's Serial CT Response Score (Serial CTRS) AI model. Serial CTRS is an AI-based prognostic tool that uses deep learning to analyze CT scans and stratify patients into high- or low-mortality risk categories.
Payers have reportedly use artificial intelligence algorithms to deny routine requests for PET imaging, instead steering patients to CCTA in some cases.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Canon Medical Systems USA is partnering with the American Healthcare Radiology Administrators (AHRA) for the latter's Living Our Legacy campaign. Canon is donating $250,000 to the AHRA in a five-year commitment, contributing $50,000 each year through 2028. This money will support initiatives such as the Putting Patients First Program, for which the AHRA will award five $10,000 grants to support projects in diagnostic imaging, pediatric imaging, and radiation safety.
There are numerous radiotracers specifically designed to identify prostate cancer, but experts say one may be superior to the others at both the patient and lesion level.
Current or past smoking does not appear to be significantly associated with radiographic progression in patients with psoriatic arthritis (PsA), according to a group of researchers from the University of Toronto. The findings are paradoxical, given that associations between smoking and radiographic damage have been established in axial spondyloarthritis and rheumatoid arthritis, noted lead author Fadi Kharouf, MD, and colleagues.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
A California appeals court recently ruled in favor of on-call radiologist Peymam Kangavari, MD, after he was accused of overlooking a bowel obstruction on X-ray and ultrasound images.
Bracco Imaging has received fast-track designation from the U.S. Food and Drug Administration (FDA) for development of the company's BR55 imaging agent for detecting areas of active bowel inflammation in patients with Crohn's disease. BR55 is a novel molecular imaging ultrasound contrast agentdesigned to specifically target the vascular endothelial growth factor receptor 2 (VEGFR2), a biomarker for Crohn's disease.
The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
Ultrasound-guided cryoablation can be considered for breast cancer patients who are poor surgical candidates or who refuse surgery, suggest findings published February 3 in the Journal of Vascular and Interventional Radiology. Researchers led by Jolie Jean, MD, from New York-Presbyterian Hospital/Weill Cornell Imaging in New York found a recurrence rate of 10% when following up with women who underwent cryoablation at an average of 21 months after the procedure.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
Using photon-counting CT (PCCT) with the gadolinium-based contrast agent (GBCA) gadoxetate disodium shows promise for improved liver visualization at a lower dose than is required for CT exams using other GBCA agents, researchers have reported. But more research is needed, as the gadoxetate disodium dose -- 200-mol/kg -- is still too high for clinical use, wrote a team led by Stephen Rau, MD, of the University of Freiburg in Germany.
A team of physicists has developed a groundbreaking method for detecting congestive heart failure with greater ease and precision than previously thought possible. This multidisciplinary study, involving both cardiologists and computational physicists, builds on the team's earlier breakthroughs, for example, in predicting the risk of sudden cardiac death.
Wellumio, aNew Zealand-based medical device company specializing in stroke detection, has enrolled the first patient in a feasibility, safety, and usability assessment of its Axana 0.1-tesla portable MRI device. A Melbourne, Australia-basedhospitalrecently used Axana to perform an exam on a 77-year-old woman suspected of acute stroke. The study willbe a two-part, dual-center, feasibility/observational study of the device, with the primary objective being to assess the safety and feasibility of A
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Applications of adipose-derived stem cells span orthopaedics, neurology, cardiology, urology, aesthetics, and regenerative medicine. The post Advancements in Stem Cell Therapies: Exploring the Clinical Applications of Adipose-Derived Stem Cells appeared first on Open MedScience.
AISAP has partnered with Miami, FL-based Amavita Heart and Vascular Health to offer its AISAP Cardio point-of-care ultrasound (POCUS) software platform outside of hospital settings to underserved communities in South Florida. Amavita has begun deploying the software in screenings for aortic stenosis and other valvular diseases in its clinics, local skilled nursing facilities, and mobile screening units in underserved communities.
The state of Washington is considering a bill authorizing diagnostic radiologic technologists (RTs), therapeutic RTs, and MRI technologists to perform intravenous contrast procedures under "general supervision," rather than direct supervision of a physician. House Bill (HB) 1546 sets out to authorize parenteral procedures related to radiologic technology when performed under the general supervision of a physician or osteopathic physician.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content